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Supplementary Figure 1. RNA analysis of SLC7A11 gene-trap clone 
SLC7A11 mRNA levels measured by real-time PCR in wildtype Hap1 (WT) and AC6 (SLC7A11 
gene-trap clone) cells. Cells were cultured with in media with the indicated glucose 
concentration for 16 hr. GAPDH was used for real-time RT-PCR normalization. Data represent 
the means ± s.d. (n=3); **, p<0.01; unpaired Student’s t-test. 
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Supplementary Figure 2. Proliferation and cell viability assays for SLC7A11-knockdown 
Hap1 and SLC7A11-overexpressing HeLa cells 
(a) Proliferation rates in glucose-replete media. The medium was DMEM A14430 containing 10% 
dialyzed FBS, 10 mM glucose and 6 mM glutamine. Data represent the means ± s.d. (n=3). (b) 
Cell viability in low glucose media. Cell were cultured in DMEM A14430 containing 10% 
dialyzed FBS, 0.2 mM glucose and 1 mM glutamine for 2 days. Data represent the means ± s.d. 
(n=3). (c) Viability in glutamine-deficient media. Cells were cultured in glutamine-deficient 
medium (DMEM A14430 containing 10% dialyzed FBS, 10 mM glucose and 0 mM glutamine) 
for 3 days and cell viability was determined. Data represent the means ± s.d. (n=3). 
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Supplementary Figure 3. Glutamate, glutathione, cell viability and respiration assays 
(a) Quantification of intracellular glutamate of Hap1 gene-trap mutants before and one hour after 
glucose removal. Data represents the mean ± s.d. (n=3); **, p<0.01; unpaired Student’s t-test. 
(b) Quantification of intracellular total glutathione of Hap1 and HeLa cells at 1 hour after glucose 
removal. Data represents the mean ± s.d. (n=3); **, p<0.01; unpaired Student’s t-test. (c, d) Cell 
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viability at 24 hr after glucose withdrawal.  The following drugs were added as indicated: 0.5 mM 
AOA, 50 µM EGCG, 10 µM BPTES or 4 mM dm-aKG. Data represents the mean ± s.d. (n=3). (e) 
Viability of Hap1 and Hs578T cells in glucose-deficient medium with varying glutamine 
supplementation. Cells were incubated with medium (DMEM A14430 containing 10% dialyzed 
FBS, 0 mM glucose, and 1, 5 or 10 mM glutamine) for 24 hr and cell viability was determined. 
Data represent the means ± s.d. (n=3). (f) Oxygen consumption under glucose-replete 
conditions. OCR in SLC7A11 knockdown Hap1 cells and SLC7A11-overexpressing HeLa cells 
was measured in the presence of 10 mM glucose + 6 mM glutamine. Data represents the mean 
± s.d. (n=4). (g) Metabolic labeling with isotope-labeled glutamine. Cells were incubated for 8 hr 
in glucose free media containing U-13C5-glutamine before extracting metabolites. Data represent 
the means ± s.d. (n=3). 
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Supplementary Figure 4. Correlation of SLC7A11 and OXPHOS gene expression in breast 
cancer cell lines 
(a) Heatmap of gene expression values of SLC7A11 and OXPHOS complex genes across 59 
breast cancer cells in the CCLE expression data. 59 breast cancer cells are arranged in the 
order of SLC7A11 expression level from lowest (blue) to highest (red). (b) Correlation coefficient 
(R) between expression of SLC7A11 and that of all other genes (n = 18987) or OXPHOS genes 
(n = 93) across 59 breast cancer cells. The two-sided Student’s t test was used to calculate p 
values.  
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Supplementary Figure 5. SLC7A11 expression and ROS level in breast cancer cells 
(a) Glutamate release into the medium. All values were normalized to glutamate release of 
Hap1 control cells shown in Fig. 2b. Data represent the means ± s.d. (n=3); **, p<0.01; unpaired 
Student’s t-test. (b) Intracellular glutamate levels before and 1 hr after glucose removal. Values 
are normalized to control cells at 0 hr. Data represent the means ± s.d. (n=3); **, p<0.01; 
unpaired Student’s t-test. (c) Cellular ROS levels in SLC7A11 knockdown and SLC7A11-
overexpressing Hs578T cells determined by flow cytometer analysis of 10 µM 2', 7'-
dichlorofluorescin diacetate (DCFH-DA) fluorescence. Cells were cultured in DMEM A14430 
containing 10% dialyzed FBS, 10 mM glucose and 2 mM glutamine. The right panel data 
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represent the means ± s.d. (n=3); **, p<0.01; unpaired Student’s t-test. (d) Maintenance of 
respiratory chain activity upon glucose withdrawal. Oxygen consumption was determined at 2 hr 
intervals after glucose withdrawal, in the presence of 1 mM glutamine. Data represent the 
means ± s.d. (n=3). 
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Supplementary Figure 6. Analysis of cybrids 
(a) Western blot of SLC7A11 levels in HeLa and 143B cells treated with rotenone (1 µM), 
oligomycin (5 µM) or antimycin A (5 µM). (b, c) Western blot of SLC7A11 levels in SLC7A11, 
Nrf2 and Atf4-knockdown or N-acetylcysteine-treated NARP cybrid cells. (d) Quantification of 
intracellular a-ketoglutarate at 6 hr after galactose culture. SLC7A11 knockdown or 
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sulfasalazine (SASP)-treated (500 µM) ND1 and NARP cells were cultured in the presence of 
10 mM galactose + 2 mM glutamine. Data represents the mean ± s.d. (n=3); *, p<0.05. **, 
p<0.01; unpaired Student’s t-test. (e) Proliferation rates of control and SLC7A11 knockdown 
143B cells. Cells were cultured in galactose medium (DMEM A14430 containing 10% dialyzed 
FBS, 10 mM galactose and 2 mM glutamine) for 3 days. Data represent the means ± s.d. (n=4). 
(f) Quantification of mitochondrial morphology. Cells were cultured in the presence of 10 mM 
glucose + 2 mM glutamine. Data represent the means ± s.d. (n=3). (g) Western blot of 
mitochondrial dynamics proteins. Cells were cultured in the presence of 10 mM glucose or 
galactose + 2 mM glutamine for 24 hr. 
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Supplementary Figure 7. Uncropped scans of key Western blots 
 
